Xu X, Kwon J, Yan R, Apio C, Song S, Heo G
JAMA Netw Open. 2025; 8(3):e250562.
PMID: 40067298
PMC: 11897841.
DOI: 10.1001/jamanetworkopen.2025.0562.
Liu H, Zhang X, Liu Q
Front Big Data. 2025; 8:1515341.
PMID: 40052173
PMC: 11882605.
DOI: 10.3389/fdata.2025.1515341.
Manning C, Youngkin A, Quigg M
J Alzheimers Dis Rep. 2025; 9:25424823241300981.
PMID: 40034516
PMC: 11864253.
DOI: 10.1177/25424823241300981.
Cai W, Neitzel J, Glodzik L, Blacker D, Ma Y
Neurology. 2025; 104(6):e213441.
PMID: 40014836
PMC: 11874733.
DOI: 10.1212/WNL.0000000000213441.
Vattathil S, Blostein F, Miller-Fleming T, Davis L, Wingo T, Wingo A
medRxiv. 2025; .
PMID: 39974048
PMC: 11838693.
DOI: 10.1101/2025.01.31.25321498.
Digital Migration of the Loewenstein Acevedo Scales for Semantic Interference and Learning (LASSI-L): Development and Validation Study in Older Participants.
Harvey P, Curiel-Cid R, Kallestrup P, Mueller A, Rivera-Molina A, Czaja S
JMIR Ment Health. 2025; 12:e64716.
PMID: 39970376
PMC: 11864698.
DOI: 10.2196/64716.
Optimizing Machine Learning Models for Accessible Early Cognitive Impairment Prediction: A Novel Cost-effective Model Selection Algorithm.
Shubar A, Ramakrishnan K, Ho C
IEEE Access. 2025; 12:180792-180814.
PMID: 39902153
PMC: 11790289.
DOI: 10.1109/access.2024.3505038.
Association of Alzheimer's and Lewy body disease pathology with basal forebrain volume and cognitive impairment.
Schumacher J, Teipel S, Storch A
Alzheimers Res Ther. 2025; 17(1):28.
PMID: 39865328
PMC: 11771035.
DOI: 10.1186/s13195-025-01678-x.
Improving estimation efficiency for survival data analysis by integrating a coarsened time-to-event outcome from an external study.
Deng D, Zhang L, Feng H, Chinchilli V, Chen C, Wang M
Biometrics. 2025; 81(1).
PMID: 39835592
PMC: 11747882.
DOI: 10.1093/biomtc/ujae168.
The Dynamics of Cognitive Decline towards Alzheimer's Disease Progression: Results from ADSP-PHC's Harmonized Cognitive Composites.
Kang K, Zhang P, Dumitrescu L, Mukherjee S, Lee M, Choi S
medRxiv. 2025; .
PMID: 39830238
PMC: 11741457.
DOI: 10.1101/2025.01.01.25319850.
Unraveling the clinical-pathological correlations of subjects with isolated and mixed neurodegenerative processes in the National Alzheimer's Coordinating Center dataset.
Hiya S, Maldonado-Diaz C, Rohde S, Gonzales M, Canbeldek L, Kulumani Mahadevan L
J Neuropathol Exp Neurol. 2024; 84(3):177-194.
PMID: 39728026
PMC: 11842910.
DOI: 10.1093/jnen/nlae134.
Robust, fully-automated assessment of cerebral perivascular spaces and white matter lesions: a multicentre MRI longitudinal study of their evolution and association with risk of dementia and accelerated brain atrophy.
Barisano G, Iv M, Choupan J, Hayden-Gephart M
EBioMedicine. 2024; 111():105523.
PMID: 39721217
PMC: 11732520.
DOI: 10.1016/j.ebiom.2024.105523.
Association of APOE alleles and polygenic profiles comprising APOE-TOMM40-APOC1 variants with Alzheimer's disease neuroimaging markers.
Kulminski A, Jain-Washburn E, Nazarian A, Wilkins H, Veatch O, Swerdlow R
Alzheimers Dement. 2024; 21(2):e14445.
PMID: 39713891
PMC: 11848341.
DOI: 10.1002/alz.14445.
Factors associated with care-resistant behavior in the National Alzheimer's Coordinating Center's Uniform Data Set.
Bratches R, Backhouse T, Barr P, Lee C, Puga F, Jablonski R
Alzheimers Dement. 2024; 21(2):e14451.
PMID: 39711331
PMC: 11851324.
DOI: 10.1002/alz.14451.
Lewy body co-pathology in Alzheimer's disease and primary age-related tauopathy contributes to differential neuropathological, cognitive, and brain atrophy patterns.
Almeida F, Santos A, Jesus T, Coelho A, Quintas-Neves M, Gauthreaux K
Alzheimers Dement. 2024; 21(1):e14191.
PMID: 39711133
PMC: 11772724.
DOI: 10.1002/alz.14191.
Distinct medical and substance use histories associate with cognitive decline in Alzheimer's Disease.
Mansel C, Mazzotti D, Townley R, Sardiu M, Swerdlow R, Honea R
medRxiv. 2024; .
PMID: 39649607
PMC: 11623748.
DOI: 10.1101/2024.11.26.24317918.
Neuropsychiatric Symptoms Associated With Frontotemporal Atrophy in Older Adults Without Dementia.
Liampas I, Siokas V, Stamati P, Kyriakoulopoulou P, Tsouris Z, Zoupa E
Int J Geriatr Psychiatry. 2024; 39(12):e70008.
PMID: 39617744
PMC: 11609132.
DOI: 10.1002/gps.70008.
The Consortium for Clarity in ADRD Research Through Imaging (CLARiTI).
Mormino E, Biber S, Rahman-Filipiak A, Arfanakis K, Clark L, Dage J
Alzheimers Dement. 2024; 21(1):e14383.
PMID: 39588767
PMC: 11772703.
DOI: 10.1002/alz.14383.
Conversion to Alzheimer's disease dementia from normal cognition directly or with the intermediate mild cognitive impairment stage.
Lu X, Zhang Y, Tang Y, Bernick C, Shan G
Alzheimers Dement. 2024; 21(1):e14393.
PMID: 39560003
PMC: 11772698.
DOI: 10.1002/alz.14393.
Pure LATE-NC: Frequency, clinical impact, and the importance of considering APOE genotype when assessing this and other subtypes of non-Alzheimer's pathologies.
Katsumata Y, Wu X, Aung K, Fardo D, Woodworth D, Sajjadi S
Acta Neuropathol. 2024; 148(1):66.
PMID: 39546031
PMC: 11568059.
DOI: 10.1007/s00401-024-02821-y.